EVA MARÍA
CIRUELOS GIL
Profesora asociada de Ciencias de la Salud
Hospital San Pedro de Alcántara
Cáceres, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital San Pedro de Alcántara (3)
2020
2019
-
Safety of eribulin as third-line chemotherapy in HER2-negative, advanced breast cancer pre-treated with taxanes and anthracycline: OnSITE study
Breast Journal, Vol. 25, Núm. 2, pp. 219-225
2016
-
Single arm, multicentre, non-randomized open-label trial to evaluate the safety of eribulin in third line chemotherapy in patients with HER2-negative metastatic or locally advanced breast cancer previously treated with anthracyclines and taxanes: Onsite study (ONCOSUR 2012-02)
Annals of Oncology, Vol. 27, pp. vi76